The subtext of both SV Labs’ and MidSolid’s recent capacity expansion news is that demand for regional production is up—in the US and other major markets.
India is a rapidly developing beauty market. And this past February, kdc/one (Longueuil, Québec, Canada) and Clarion Group (Mumbai, India) incorporated a joint venture in India. Known as kdc/one Clarion Beauty Pvt Ltd, the venture brings together two renowned contract manufacturing companies to provide both local and international brands with product formulation and packaging manufacturing. As Clarion Group Chairman K N Lakshmanan told the press in March, the “two companies not only have complementary manufacturing, formulation and packaging strengths in the beauty and personal care products sector, but…also share a commitment to providing the highest level of innovation, quality, service, agility and regulatory compliance.”
And he went on to emphasize the demand for beauty manufacturing from local as well as cross-border brands, saying “We are excited by the huge potential of this joint venture and believe that together, we will be the partner of choice for brand owners,…whether they are already operating in the Indian market or looking to enter the region.”
The legacy, multi-national manufacturer Intercos (Agrate, northeast of Milan, Italy) is also making moves to further expand the company’s operational footprint and meet demand for regional production. In September, Intercos CEO Renato Semerari told Bloomberg journalists Flavia Rotondi and Antonio Vanuzzo that the beauty maker is looking to add to its 16 production facilities by acquiring a company in the US, one generating between $100 million and $200 million in annual revenue. Intercos, a cross-category company with extensive expertise in color cosmetics and 2 manufacturing facilities in the US already, “lacks the capacity in hair or skincare to win over the largest brands or emerging trendsetters in the US,” according to Semerari in his interview with Bloomberg. He and his team had, at that time, “identified one buy-out candidate” that met the criteria and were open to others. To date, no deal has been announced.
Asia-based contract manufacturers are also capitalizing on an increased demand for products produced in the States. In July, Kolmar Korea opened its second factory in Pennsylvania, spanning nearly 200,000 square feet—that’s the same state where Kolmar US headquarters are located. This new manufacturing facility is equipped to produce up to 120 million units of skincare and sun care annually. And “this is the first time a Korean cosmetics company has directly built a production facility in the US rather than acquiring one,” according to comments attributed to an unnamed Kolmar Korea spokesperson in a press release issued shortly after construction was completed. “We’re ready,” said the spokesperson “to support K-beauty brands looking to enter the US market without tariff concerns, as well as global customers aiming for North American, European, and South American markets.”
CTK acquired a new US facility in March. And now in December, that site is operational with 40,000 square feet of manufacturing sapce in addition to a 30,000 square foot logistics warehouse. The California manufacturing plant will “serve as the gateway to the US West Coast market and establish itself as the global hub for K-beauty OTC products,” according to Cheeho Choi, Head of CTK's US OTC Business. CTK is multinational contract manufacturer with capabilities in sun care, color cosmetics, skincare, personal care, and OTC care products. The new US facility is formally known as CTK OTC LABORATORIES or COL and has the capacity to produce more than 20 million units annually.